- Home
- ORMP vs IMNM Comparison
ORMP vs IMNM Comparison
Compare ORMP & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- IMNM
- Stock Information
- Founded
- ORMP 2002
- IMNM 2006
- Country
- ORMP United States
- IMNM United States
- Employees
- ORMP N/A
- IMNM N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- ORMP Health Care
- IMNM Health Care
- Exchange
- ORMP Nasdaq
- IMNM Nasdaq
- Market Cap
- ORMP N/A
- IMNM 747.7M
- IPO Year
- ORMP N/A
- IMNM 2020
- Fundamental
- Price
- ORMP $2.31
- IMNM $12.27
- Analyst Decision
- ORMP Hold
- IMNM Strong Buy
- Analyst Count
- ORMP 1
- IMNM 4
- Target Price
- ORMP N/A
- IMNM $28.75
- AVG Volume (30 Days)
- ORMP 82.3K
- IMNM 856.4K
- Earning Date
- ORMP 11-07-2024
- IMNM 11-07-2024
- Dividend Yield
- ORMP N/A
- IMNM N/A
- EPS Growth
- ORMP N/A
- IMNM N/A
- EPS
- ORMP 0.51
- IMNM N/A
- Revenue
- ORMP N/A
- IMNM $10,784,000.00
- Revenue This Year
- ORMP N/A
- IMNM N/A
- Revenue Next Year
- ORMP N/A
- IMNM N/A
- P/E Ratio
- ORMP $4.70
- IMNM N/A
- Revenue Growth
- ORMP N/A
- IMNM 62.73
- 52 Week Low
- ORMP $1.67
- IMNM $6.93
- 52 Week High
- ORMP $3.67
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- ORMP 46.89
- IMNM 35.02
- Support Level
- ORMP $2.34
- IMNM $11.73
- Resistance Level
- ORMP $2.41
- IMNM $12.46
- Average True Range (ATR)
- ORMP 0.07
- IMNM 0.71
- MACD
- ORMP -0.00
- IMNM -0.19
- Stochastic Oscillator
- ORMP 24.00
- IMNM 6.63
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.